Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × monalizumab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Neoplasms 1

Interventions

pembrolizumab 54 Carboplatin 41 Docetaxel 30 Pemetrexed 29 Paclitaxel 29 Cisplatin 26 Nivolumab 22 Gemcitabine 21 Erlotinib Hydrochloride 19 Bevacizumab 16 Ipilimumab 10 osimertinib 9 atezolizumab 9 Radiosurgery 9 Drug Therapy 9 Cyclophosphamide 9 Cetuximab 9 Radiotherapy 8 Blood Specimen Collection 8 durvalumab 7 budigalimab 7 Dexamethasone 7 trametinib 6 fludarabine 6 cemiplimab 6 Taxes 6 Fluorouracil 6 130-nm albumin-bound paclitaxel 6 rovalpituzumab tesirine 5 avelumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03822351 2024-10-08

COAST

MedImmune LLC

Phase 2 Completed

189 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡